Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds

Details for Australian Patent Application No. 2002326664 (hide)

Owner ULURU Inc.

Inventors Nowotnik, David P; Moro, Daniel G; Callahan, Howard

Agent Pizzeys

Pub. Number AU-B-2002326664

PCT Number PCT/US02/26083

PCT Pub. Number WO2003/015748

Priority 09/931,319 16.08.01 US

Filing date 16 August 2002

Wipo publication date 3 March 2003

Acceptance publication date 6 March 2008

International Classifications

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61F 2/02 (2006.01) Filters - Prostheses implantable into the body

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 31/05 (2006.01)

A61K 31/085 (2006.01)

A61K 31/122 (2006.01) - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61K 31/131 (2006.01) - acyclic

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/14 (2006.01) - Quaternary ammonium compounds, e.g. edrophonium, choline

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/19 (2006.01)

A61K 31/195 (2006.01)

A61K 31/196 (2006.01)

A61K 31/197 (2006.01)

A61K 31/235 (2006.01)

A61K 31/31 (2006.01)

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/36 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/404

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): 09/931,319 16.08.01 US

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2002326664

29 March 2007 Assignment before Grant

  Access Pharmaceuticals, Inc. The application has been assigned to ULURU Inc.

6 March 2008 Application Accepted

  Published as AU-B-2002326664

3 July 2008 Standard Patent Sealed

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002326665-TECHNIQUE TO MINIMIZE CROSSTALK IN ELECTRONIC PACKAGES

2002326663-FIXTURES FOR USE IN PARALLEL PROCESSING BIO-CHIPS